Research Progress of Traditional Chinese Medicine in Adjuvant Treatment of Type 1 Diabetes

被引:0
作者
Luo, Jian [1 ]
Hu, Fuli [1 ]
Jia, Zhuolin [1 ]
Zhu, Xiaoli [1 ]
Zhou, Ye [1 ]
Hu, Changhe [2 ]
Yu, Lingying [1 ]
Chen, Zhimin [1 ,3 ]
机构
[1] Chengdu Univ Tradit Chinese Med, Sch Pharm, Sch Modern Chinese Med Ind, State Key Lab Southwestern Chinese Med Resources, Chengdu, Peoples R China
[2] Tradit Hosp Dachuan Cty Dazhou, Dazhou, Peoples R China
[3] Chengdu Univ Tradit Chinese Med, Pengzhou, Sichuan, Peoples R China
关键词
action mechanism; combination of traditional Chinese medicine with western medicine; traditional Chinese medicine; type; 1; diabetes; SALVIANOLIC ACID B; INSULIN-RESISTANCE; OXIDATIVE STRESS; LIUWEI DIHUANG; PORIA-COCOS; PPAR-GAMMA; INDUCED HYPERGLYCEMIA; GINSENOSIDE RB1; HERBAL MEDICINE; MOLECULAR-BASIS;
D O I
10.1002/ptr.8514
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Type 1 diabetes (T1DM) is one of the most common chronic metabolic diseases in the world. Insulin replacement therapy and drug adjuvant therapy are the main means of modern medical treatment of T1DM; still, there are adverse reactions such as drug resistance, which seriously hinder the therapeutic effect. As a unique medical method in China, traditional Chinese medicine (TCM) has a significant effect on the treatment of T1DM. TCM therapy can reduce the symptoms of T1DM, prevent complications, improve insulin resistance, and promote insulin secretion. In recent years, the research field of TCM in the treatment of T1DM has made considerable progress. The research on the treatment of T1DM by Chinese herbal medicine, TCM prescription, acupuncture, and moxibustion shows good anti-T1DM effect and significantly improves the survival rate of patients. This article aims to summarize the methods of TCM in the treatment of T1DM, expounds on the mechanism of action in the treatment of T1DM, and discusses the limitations and opportunities of TCM in the treatment of T1DM.
引用
收藏
页数:37
相关论文
共 224 条
[21]   The promising future of insulin therapy in diabetes mellitus [J].
Cheng, Ran ;
Taleb, Nadine ;
Stainforth-Dubois, Meggie ;
Rabasa-Lhoret, Remi .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (05) :E886-E890
[22]  
Cheng W., 2023, Global Traditional Chinese Medicine, V16, P1002
[23]   Schisandrae chinensis Fructus Extract Ameliorates Muscle Atrophy in Streptozotocin-Induced Diabetic Mice by Downregulation of the CREB-KLF15 and Autophagy-Lysosomal Pathways [J].
Choi, Ho-Jung ;
Yeon, Myeong-Hoon ;
Jun, Hee-Sook .
CELLS, 2021, 10 (09)
[24]   Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies? [J].
Citro, Antonio ;
Campo, Francesco ;
Dugnani, Erica ;
Piemonti, Lorenzo .
FRONTIERS IN ENDOCRINOLOGY, 2021, 11
[25]   Early-life factors contributing to type 1 diabetes [J].
Craig, Maria E. ;
Kim, Ki Wook ;
Isaacs, Sonia R. ;
Penno, Megan A. ;
Hamilton-Williams, Emma E. ;
Couper, Jennifer J. ;
Rawlinson, William D. .
DIABETOLOGIA, 2019, 62 (10) :1823-1834
[26]  
CunRong L., 2024, Journal of Liaoning University of Traditional Chinese Medicine, V51, P40, DOI [10.13192/j.issn.1000-1719.2024.07.012, DOI 10.13192/J.ISSN.1000-1719.2024.07.012]
[27]   Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales [J].
Dahlen, Amelia D. ;
Dashi, Giovanna ;
Maslov, Ivan ;
Attwood, Misty M. ;
Jonsson, Joergen ;
Trukhan, Vladimir ;
Schioth, Helgi B. .
FRONTIERS IN PHARMACOLOGY, 2022, 12
[28]   SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice [J].
Dai, Xuan ;
Liu, Yage ;
Liu, Tianyuan ;
Zhang, Yueyi ;
Wang, Shan ;
Xu, Tianshu ;
Yin, Jiyuan ;
Shi, Hanfen ;
Ye, Zimengwei ;
Zhu, Ruyuan ;
Gao, Junfeng ;
Dong, Guangtong ;
Zhao, Dandan ;
Gao, Sihua ;
Wang, Xinxiang ;
Prentki, Marc ;
Bromme, Dieter ;
Wang, Lili ;
Zhang, Dongwei .
JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
[29]   Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study [J].
de Vries, Sieta T. ;
Denig, Petra ;
Ekhart, Corine ;
Mol, Peter G. M. ;
van Puijenbroek, Eugene P. .
DRUG SAFETY, 2020, 43 (05) :489-495
[30]   The Role of TCF7L2 in Type 2 Diabetes [J].
del Bosque-Plata, Laura ;
Martinez-Martinez, Eduardo ;
Angel Espinoza-Camacho, Miguel ;
Gragnoli, Claudia .
DIABETES, 2021, 70 (06) :1220-1228